Showing results (271-280 of 321) with videos related to

Sort By:
Pageof 33
Frontiers in Genetics|April 30, 2019
Integrative Approach to Reveal Cell Type Specificity and Gene Candidates for Psoriatic Arthritis Outside the MHCMatthew T Patrick, Philip E Stuart, Kalpana Raja, et al.
Rheumatology (Oxford, England)|April 6, 2021
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studiesDennis McGonagle, Iain B McInnes, Atul Deodhar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 12, 2020
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic ArthritisIain B McInnes, Proton Rahman, Alice B Gottlieb, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 11, 2002
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosusPatricia L Dobkin, Deborah Da Costa, Lawrence Joseph, et al.
The Journal of Rheumatology|May 8, 2003
Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosusSteven M Edworthy, Patricia L Dobkin, Ann E Clarke, et al.
Arthritis Research & Therapy|September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunityJoan Wither, Yong-chun Cai, Sooyeol Lim, et al.
The Journal of Rheumatology|May 2, 2021
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic ArthritisProton Rahman, Christopher T Ritchlin, Philip S Helliwell, et al.
Pageof 33